In line with this observation, anergic CLL cells exhibited a significant downregulation of surface IgM expression as compared to physiological B cells, while CLL cells with Nfat2 deletion showed an upregulation (Fig. 7b). This evidence concerns the gene NFATC1 and B-cell chronic lymphocytic leukemia.